Bayer has offered additional concessions to European regulators regarding its $63.5 billion bid for Creve Coeur-based Monsanto in an antitrust review that will now be extended to April 5.
The proposed remedies “are very significant and we are confident they fully address the European Commission’s concerns,” Bayer said in a statement.
The European Commission said that the deadline for it to conclude its antitrust investigation had been postponed to April 5 from March 12 previously.
Bayer maintained it was still aiming to wrap up the deal “in early 2018.”
Both the EU Commission and Bayer declined to say what assets Bayer had offered to put on the block.
Read more: St. Louis Post-Dispatch